The potential of targeting autophagy-related non-coding RNAs in the treatment of lung cancer
Lung cancer is the most prevalent malignant tumor worldwide and remains the leading cause of cancer-related mortality. Despite advances in treatment development, lung cancer patients often face poor quality of life and low survival rates. Increasing evidence highlights the significant roles of autop...
Saved in:
| Main Authors: | Juan Li, Jimei Gan, Shenggan Shi, Juying Huang, Yong Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1551258/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosomal long non-coding RNAs in gastrointestinal cancer: chemoresistance mediators and therapeutic targets
by: Chenhe Li, et al.
Published: (2025-08-01) -
Novel insights into non-coding RNAs and their role in hydrocephalus
by: Zhiyue Cui, et al.
Published: (2026-02-01) -
Editorial: Non-coding RNAs in breast cancer, volume II
by: Wenwen Zhang, et al.
Published: (2025-02-01) -
Editorial: Autophagy and lung cancer therapy: targeted drug development and new emerging technology
by: Ming Zhang, et al.
Published: (2025-04-01) -
RNA-binding proteins and autophagy in lung cancer: mechanistic insights and therapeutic perspectives
by: Xiao Lei, et al.
Published: (2025-04-01)